Cargando…
Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies
A new class of glycan-reactive HIV-neutralizing antibodies, including PG9 and PG16, has been recently discovered that appear to recognize novel glycopeptide epitopes on HIV-1 gp120. However, further characterization and reconstitution of the precise neutralizing epitopes are complicated by the heter...
Autores principales: | Amin, Mohammed N., McLellan, Jason S., Huang, Wei, Orwenyo, Jared, Burton, Dennis R., Koff, Wayne C., Kwong, Peter D., Wang, Lai-Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730851/ https://www.ncbi.nlm.nih.gov/pubmed/23831758 http://dx.doi.org/10.1038/nchembio.1288 |
Ejemplares similares
-
Multivalent Antigen Presentation Enhances the Immunogenicity of a Synthetic Three-Component HIV-1 V3 Glycopeptide Vaccine
por: Cai, Hui, et al.
Publicado: (2018) -
Chemoenzymatic synthesis of glycopeptides bearing rare N-glycan sequences with or without bisecting GlcNAc
por: Yang, Weizhun, et al.
Publicado: (2018) -
N332-Directed Broadly Neutralizing Antibodies Use Diverse Modes of HIV-1 Recognition: Inferences from Heavy-Light Chain Complementation of Function
por: Pancera, Marie, et al.
Publicado: (2013) -
Structural comparison of somatically related PG9 and PG16 in complex with their epitope reveals differences in glycan recognition
por: Pancera, M, et al.
Publicado: (2012) -
Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies
por: Julien, J, et al.
Publicado: (2012)